{"id":4596,"date":"2026-02-10T12:40:07","date_gmt":"2026-02-10T11:40:07","guid":{"rendered":"https:\/\/usk.empressia.dev\/?post_type=usk_project_test&#038;p=4596"},"modified":"2026-05-12T12:54:43","modified_gmt":"2026-05-12T10:54:43","slug":"projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial","status":"publish","type":"usk_project_test","link":"https:\/\/www.usk.poznan.pl\/ua\/projekty\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\/","title":{"rendered":"Projekt \u201eComparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis \u2013 the head to head COMBO-UC trial\u201d"},"content":{"rendered":"    <section\n    class=\"logos-grid content-grid full-width @container  bg-light text-dark is-style-small-margin\"\n    \n    data-gallery-id=\"\"\n  >\n    <div class=\"flex gap-16 flex-wrap items-center @3xl:flex-nowrap @5xl:gap-36\">\n                      <a\n          href=\"https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/01\/znak_barw_rp_poziom_szara_ramka_rgb-e1771342381987.png\"\n          data-fslightbox=\"\"\n          class=\"cursor-pointer overflow-hidden h-70 [&#038;_svg]:h-full [&#038;_svg]:w-auto @3xl:h-100\"\n        >\n          \n\n\n\t\n\t\t\t\t\n\t\n\t<img decoding=\"async\" width=\"768\" height=\"181\" src=\"https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/01\/znak_barw_rp_poziom_szara_ramka_rgb-e1771342381987-768x181.png\" class=\"object-contain h-full w-auto\" alt=\"Logotyp Rzeczpospolita Polska\" loading=\"lazy\" srcset=\"https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/01\/znak_barw_rp_poziom_szara_ramka_rgb-e1771342381987-768x181.png 768w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/01\/znak_barw_rp_poziom_szara_ramka_rgb-e1771342381987-300x71.png 300w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/01\/znak_barw_rp_poziom_szara_ramka_rgb-e1771342381987-1024x241.png 1024w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/01\/znak_barw_rp_poziom_szara_ramka_rgb-e1771342381987-1536x362.png 1536w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/01\/znak_barw_rp_poziom_szara_ramka_rgb-e1771342381987-18x4.png 18w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/01\/znak_barw_rp_poziom_szara_ramka_rgb-e1771342381987-500x118.png 500w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/01\/znak_barw_rp_poziom_szara_ramka_rgb-e1771342381987.png 1817w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/>\n\n        <\/a>\n                      <a\n          href=\"https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/godlo_polski.svg.png\"\n          data-fslightbox=\"\"\n          class=\"cursor-pointer overflow-hidden h-70 [&#038;_svg]:h-full [&#038;_svg]:w-auto @3xl:h-100\"\n        >\n          \n\n\n\t\n\t\t\t\t\n\t\n\t<img decoding=\"async\" width=\"509\" height=\"599\" src=\"https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/godlo_polski.svg.png\" class=\"object-contain h-full w-auto\" alt=\"godlo polski\" loading=\"lazy\" srcset=\"https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/godlo_polski.svg.png 509w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/godlo_polski.svg-255x300.png 255w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/godlo_polski.svg-10x12.png 10w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/godlo_polski.svg-500x588.png 500w\" sizes=\"(max-width: 509px) 100vw, 509px\" \/>\n\n        <\/a>\n                      <a\n          href=\"https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/ABM_logo_2-1.png\"\n          data-fslightbox=\"\"\n          class=\"cursor-pointer overflow-hidden h-70 [&#038;_svg]:h-full [&#038;_svg]:w-auto @3xl:h-100\"\n        >\n          \n\n\n\t\n\t\t\t\t\n\t\n\t<img decoding=\"async\" width=\"508\" height=\"191\" src=\"https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/ABM_logo_2-1.png\" class=\"object-contain h-full w-auto\" alt=\"Agencja Bada\u0144 medycznych\" loading=\"lazy\" srcset=\"https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/ABM_logo_2-1.png 508w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/ABM_logo_2-1-300x113.png 300w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/ABM_logo_2-1-18x7.png 18w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/ABM_logo_2-1-500x188.png 500w\" sizes=\"(max-width: 508px) 100vw, 508px\" \/>\n\n        <\/a>\n          <\/div>\n  <\/section>\n\n\n\n<p>Uniwersytecki Szpital Kliniczny w Poznaniu realizuje projekt \u201eComparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis \u2013 the head to head COMBO-UC trial\u201d.<\/p>\n\n\n\n<p>Projekt realizowany jest przez Konsorcjum w sk\u0142adzie:<br><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Uniwersytet Medyczny w \u0141odzi (Lider)<\/li>\n\n\n\n<li>Samodzielny Publiczny Zak\u0142ad Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w \u0141odzi (Partner)<\/li>\n\n\n\n<li>Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu (Partner)<\/li>\n\n\n\n<li>Uniwersytecki Szpital Kliniczny w Poznaniu (Partner)<\/li>\n<\/ul>\n\n\n\n<p>Projekt finansowany jest ze \u015brodk\u00f3w Agencji Bada\u0144 Medycznych w ramach Konkursu na badania head-to-head w zakresie niekomercyjnych bada\u0144 klinicznych lub eksperyment\u00f3w badawczych, nr ABM\/2022\/3.<br><br>Numer umowy: 2022\/ABM\/03\/00013.<br>Kwota dofinansowania projektu:&nbsp;<strong>19 868 246,28 z\u0142.<\/strong><br>Kwota dofinansowania dla&nbsp;Uniwersyteckiego Szpitala Klinicznego w Poznaniu:&nbsp;<strong>1&nbsp;577&nbsp;202,00 z\u0142.<\/strong><\/p>\n\n\n\n<p>OPIS PROJEKTU:<\/p>\n\n\n\n<p>Badanie kliniczne w ramach Projektu dotyczy pacjent\u00f3w z wrzodziej\u0105cym zapaleniem jelita grubego, dla kt\u00f3rych w przypadku nieskuteczno\u015bci terapii konwencjonalnych standardem leczenia jest monoterapia lekami biologicznymi. Natomiast z uwagi na fakt, i\u017c odsetek uzyskanych w ten spos\u00f3b remisji klinicznych nadal nie jest zadowalaj\u0105cy, w ramach badania proponujemy terapi\u0119 \u0142\u0105czon\u0105 dwoma lekami biologicznymi (Infliximab: IFX oraz Ustekinumab: UST).<\/p>\n\n\n\n<p>Planowane badanie to trzyramienne, r\u00f3wnoleg\u0142e, randomizowane badanie typu head to head z jedn\u0105 grup\u0105 eksperymentaln\u0105 (IFX + UST) i dwiema por\u00f3wnawczymi (IFX lub UST).<\/p>\n\n\n\n<p>Planowo rekrutacja pacjent\u00f3w b\u0119dzie odbywa\u0107 si\u0119 w 8 wojew\u00f3dztwach, w wyspecjalizowanych o\u015brodkach gastroenterologicznych \u2013 przy \u0142\u0105cznym za\u0142o\u017ceniu rekrutacyjnym 172 pacjent\u00f3w.<\/p>\n\n\n\n<p>G\u0142\u00f3wny Badacz:<\/p>\n\n\n\n<p>dr hab. n.med.&nbsp;Renata&nbsp;Talar-Wojnarowska, prof. UM w \u0141odzi<\/p>\n\n\n\n<p>Projekt &#8222;Comparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis \u2013 the head to head COMBO-UC trial&#8221; finansowany jest ze \u015brodk\u00f3w Agencji Bada\u0144 Medycznych w ramach Konkursu na badania head-to-head w zakresie niekomercyjnych bada\u0144 klinicznych lub eksperyment\u00f3w badawczych, nr ABM\/2022\/3. Numer umowy: 2022\/ABM\/03\/00013.<\/p>\n\n\n\t\t<section class=\"b--gallery gallery content-grid full-width   bg-light text-dark is-style-small-margin\"  data-gallery-id=\"gallery541221268\">\n\n\t\t<div class=\"grid grid-cols-2 lg:grid-cols-3 gap-12 md:gap-24\">\n\n\t\t\t\n\t\t\t\t\t\t\t\t<a href=\"https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/COMBO_UC-1.png\" data-fslightbox=\"gallery541221268\" class=\"cursor-pointer overflow-hidden rounded-8\">\n\t\t\t\t\t\n\n\n\t\n\t\t\t\t\n\t\n\t<img decoding=\"async\" width=\"768\" height=\"357\" src=\"https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/COMBO_UC-1-768x357.png\" class=\"size-full object-cover\" alt=\"Logotyp Combo-Uc\" loading=\"lazy\" srcset=\"https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/COMBO_UC-1-768x357.png 768w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/COMBO_UC-1-300x139.png 300w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/COMBO_UC-1-1024x476.png 1024w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/COMBO_UC-1-1536x714.png 1536w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/COMBO_UC-1-18x8.png 18w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/COMBO_UC-1-500x232.png 500w, https:\/\/www.usk.poznan.pl\/wp-content\/uploads\/2026\/02\/COMBO_UC-1.png 1588w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/>\n\n\t\t\t\t<\/a>\n\n\t\t\t\n\t\t<\/div>\n\n\t<\/section>\n\n","protected":false},"template":"","meta":{"_acf_changed":true},"usk_project_test_category":[100,107],"class_list":["post-4596","usk_project_test","type-usk_project_test","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Projekt \u201eComparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis \u2013 the head to head COMBO-UC trial\u201d - Uniwersytecki Szpital Kliniczny w Poznaniu<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.usk.poznan.pl\/ua\/projekty\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\/\" \/>\n<meta property=\"og:locale\" content=\"uk_UA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Projekt \u201eComparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis \u2013 the head to head COMBO-UC trial\u201d - Uniwersytecki Szpital Kliniczny w Poznaniu\" \/>\n<meta property=\"og:description\" content=\"Uniwersytecki Szpital Kliniczny w Poznaniu realizuje projekt \u201eComparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis \u2013 the head to head COMBO-UC trial\u201d. Projekt realizowany jest przez Konsorcjum w sk\u0142adzie: Projekt finansowany jest ze \u015brodk\u00f3w Agencji Bada\u0144 Medycznych w ramach Konkursu na badania head-to-head w zakresie niekomercyjnych bada\u0144 klinicznych lub eksperyment\u00f3w badawczych, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.usk.poznan.pl\/ua\/projekty\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"Uniwersytecki Szpital Kliniczny w Poznaniu\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-12T10:54:43+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u041f\u0440\u0438\u0431\u043b. \u0447\u0430\u0441 \u0447\u0438\u0442\u0430\u043d\u043d\u044f\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 \u0445\u0432\u0438\u043b\u0438\u043d\u0438\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.usk.poznan.pl\\\/projekty\\\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\\\/\",\"url\":\"https:\\\/\\\/www.usk.poznan.pl\\\/projekty\\\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\\\/\",\"name\":\"Projekt \u201eComparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis \u2013 the head to head COMBO-UC trial\u201d - Uniwersytecki Szpital Kliniczny w Poznaniu\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.usk.poznan.pl\\\/#website\"},\"datePublished\":\"2026-02-10T11:40:07+00:00\",\"dateModified\":\"2026-05-12T10:54:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.usk.poznan.pl\\\/projekty\\\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\\\/#breadcrumb\"},\"inLanguage\":\"uk\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.usk.poznan.pl\\\/projekty\\\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.usk.poznan.pl\\\/projekty\\\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Strona g\u0142\u00f3wna\",\"item\":\"https:\\\/\\\/www.usk.poznan.pl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projekty i badania\",\"item\":\"\\\/projekty-i-badania\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Projekt \u201eComparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis \u2013 the head to head COMBO-UC trial\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.usk.poznan.pl\\\/#website\",\"url\":\"https:\\\/\\\/www.usk.poznan.pl\\\/\",\"name\":\"Uniwersytecki Szpital Kliniczny w Poznaniu\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.usk.poznan.pl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"uk\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Projekt \u201eComparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis \u2013 the head to head COMBO-UC trial\u201d - Uniwersytecki Szpital Kliniczny w Poznaniu","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.usk.poznan.pl\/ua\/projekty\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\/","og_locale":"uk_UA","og_type":"article","og_title":"Projekt \u201eComparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis \u2013 the head to head COMBO-UC trial\u201d - Uniwersytecki Szpital Kliniczny w Poznaniu","og_description":"Uniwersytecki Szpital Kliniczny w Poznaniu realizuje projekt \u201eComparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis \u2013 the head to head COMBO-UC trial\u201d. Projekt realizowany jest przez Konsorcjum w sk\u0142adzie: Projekt finansowany jest ze \u015brodk\u00f3w Agencji Bada\u0144 Medycznych w ramach Konkursu na badania head-to-head w zakresie niekomercyjnych bada\u0144 klinicznych lub eksperyment\u00f3w badawczych, [&hellip;]","og_url":"https:\/\/www.usk.poznan.pl\/ua\/projekty\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\/","og_site_name":"Uniwersytecki Szpital Kliniczny w Poznaniu","article_modified_time":"2026-05-12T10:54:43+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u041f\u0440\u0438\u0431\u043b. \u0447\u0430\u0441 \u0447\u0438\u0442\u0430\u043d\u043d\u044f":"2 \u0445\u0432\u0438\u043b\u0438\u043d\u0438"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.usk.poznan.pl\/projekty\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\/","url":"https:\/\/www.usk.poznan.pl\/projekty\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\/","name":"Projekt \u201eComparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis \u2013 the head to head COMBO-UC trial\u201d - Uniwersytecki Szpital Kliniczny w Poznaniu","isPartOf":{"@id":"https:\/\/www.usk.poznan.pl\/#website"},"datePublished":"2026-02-10T11:40:07+00:00","dateModified":"2026-05-12T10:54:43+00:00","breadcrumb":{"@id":"https:\/\/www.usk.poznan.pl\/projekty\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\/#breadcrumb"},"inLanguage":"uk","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.usk.poznan.pl\/projekty\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.usk.poznan.pl\/projekty\/projekt-comparison-of-ustekinumab-infliximab-and-combination-therapy-in-moderately-to-severely-active-ulcerative-colitis-the-head-to-head-combo-uc-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Strona g\u0142\u00f3wna","item":"https:\/\/www.usk.poznan.pl\/"},{"@type":"ListItem","position":2,"name":"Projekty i badania","item":"\/projekty-i-badania\/"},{"@type":"ListItem","position":3,"name":"Projekt \u201eComparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis \u2013 the head to head COMBO-UC trial\u201d"}]},{"@type":"WebSite","@id":"https:\/\/www.usk.poznan.pl\/#website","url":"https:\/\/www.usk.poznan.pl\/","name":"Uniwersytecki Szpital Kliniczny w Poznaniu","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.usk.poznan.pl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"uk"}]}},"_links":{"self":[{"href":"https:\/\/www.usk.poznan.pl\/ua\/wp-json\/wp\/v2\/usk_project_test\/4596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.usk.poznan.pl\/ua\/wp-json\/wp\/v2\/usk_project_test"}],"about":[{"href":"https:\/\/www.usk.poznan.pl\/ua\/wp-json\/wp\/v2\/types\/usk_project_test"}],"wp:attachment":[{"href":"https:\/\/www.usk.poznan.pl\/ua\/wp-json\/wp\/v2\/media?parent=4596"}],"wp:term":[{"taxonomy":"usk_project_test_category","embeddable":true,"href":"https:\/\/www.usk.poznan.pl\/ua\/wp-json\/wp\/v2\/usk_project_test_category?post=4596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}